Atom | Mitochondrial-associated Mechanisms of Neuropathological and Immunodeficient Aging in the Context of HIV and SUD (R01 Clinical Trials Not Allowed)

Funder: National Institutes of Health

Due Dates: February 10, 2025 (Letter of Intent) | March 10, 2025 (AIDS applications) | March 10, 2026 (AIDS applications)

Funding Amounts: ~$3,000,000 total in FY 2026 for 3–6 awards (R01); budgets not limited but must reflect project needs; max project period 5 years.

Summary: Supports basic and preclinical research on mitochondrial mechanisms of aging in the context of HIV infection and substance use, aiming to inform targeted therapies for people aging with HIV and addiction.

Key Information: Clinical trials are not allowed; applications must address both HIV and substance use (not alcohol alone).

Mitochondrial-associated Mechanisms of Neuropathological and Immunodeficient Aging in the Context of HIV and SUD (R01 Clinical Trials Not Allowed)

Sign in to see full grant listing